CarbetimerAlternative Names: Carboxyimamidate; N 137; NED 137; NSC 329514D; Plimar; Polima
Latest Information Update: 18 Oct 2000
At a glance
- Originator Pharmacia Corporation; Wyeth
- Class Cytostatics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 18 Oct 2000 No-Development-Reported for Cancer (Unknown route)
- 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation
- 23 Mar 1998 Profile reviewed